Form 4: Neuronetics Director Boosts Stake with Share Grant
Insider Transaction Report
Neuronetics Director Sheryl L Conley acquired 7,326 shares of common stock as part of her non-employee director compensation plan, increasing her total beneficial ownership to 221,716 shares.
Summary
- Sheryl L Conley, a Director of Neuronetics, Inc. (STIM), acquired 7,326 shares of the company's common stock.
- The transaction occurred on October 20, 2025, and was filed on October 22, 2025.
- The shares were acquired at a price of $0, representing a restricted stock unit (RSU) award that vested immediately upon grant.
- This acquisition was made pursuant to the Issuer's non-employee directors compensation plan, where the Reporting Person elected to receive shares in lieu of a cash retainer.
- Following this transaction, Sheryl L Conley beneficially owns a total of 221,716 shares of Neuronetics, Inc. common stock.
Sentiment
Score: 7
Explanation: The sentiment is positive as a director is increasing their stake in the company, which generally indicates confidence. While it's compensation rather than a direct purchase, it still aligns the director's interests with shareholders.
Positives
- A Director is increasing their beneficial ownership in the company, which can signal confidence in the company's future prospects.
- The acquisition aligns the interests of the Director more closely with those of the shareholders.
Negatives
- The shares were acquired as compensation (RSU award) rather than an open market purchase, which might be viewed differently than a direct cash investment by an insider.
Future Outlook
NA
Industry Context
This filing is an insider transaction report and does not provide information related to broader industry trends or competitors. It reflects an individual director's compensation structure and shareholdings within Neuronetics, Inc.
Related Party Transactions
- The acquisition of shares by Director Sheryl L Conley as compensation under the non-employee directors compensation plan constitutes a related party transaction.
Stakeholder Impact
- Shareholders: Increased alignment of a director's interests with shareholder value due to higher equity ownership.
- Employees: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 10/20/2025 | Date of transaction where Sheryl L Conley acquired 7,326 shares of common stock. |
| 10/22/2025 | Date the Form 4 filing was signed and submitted. |
Recommendation
holdThe acquisition of shares by a director, even as compensation, is generally a positive signal, indicating continued alignment and confidence in the company. However, it is not an open market purchase, which would typically convey a stronger 'buy' signal. Given it's a routine compensation event, a 'hold' recommendation is appropriate, acknowledging the positive alignment without suggesting immediate strong upside solely from this transaction.
Keywords
Neuronetics, STIM, Insider Transaction, Form 4, Director Compensation, Restricted Stock Unit, Share Acquisition, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.